Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GABRD promotes progression and predicts poor prognosis in colorectal cancer

1 Jan 2020

Abstract excerpt

Little is known about the functional roles of gamma-aminobutyric acid type A receptor subunit delta (GABRD) in colorectal cancer (CRC). The expression of GABRD between CRCs and adjacent normal tissues (NTs), metastasis and primary tumors was compared using public transcriptomic datasets. A tissue microarray and immunohistochemical staining (IHC) were used to determine the clinical and prognostic significance of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Colorectal Cancer Treatments and Studies
Share to Inflammatory mediators and NSAID effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33336074
DOI: 10.1515/med-2020-0128

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GABRD promotes progression and predicts poor prognosis in colorectal cancerPMID 33336074Read ↗

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinomaSemantic proximity Read ↗

Distinct diagnostic and prognostic values of γ‑aminobutyric acid type A receptor family genes in patients with colon adenocarcinomaSemantic proximity Read ↗

Prognostic Significance of GRINA in Colorectal CancerSemantic proximity Read ↗

MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathwaySemantic proximity Read ↗

GABRQ is Overexpressed and Correlated with Tumor Progression in Breast CancerSemantic proximity Read ↗

GABRP is a potential chemoresistance regulator in colorectal cancerSemantic proximity Read ↗

Silencing GDI2 inhibits proliferation, migration and invasion of colorectal cancer through activation of p53 signaling pathwaySemantic proximity Read ↗

CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathwaySemantic proximity Read ↗

Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.Semantic proximity Read ↗

NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patientsSemantic proximity Read ↗

GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung AdenocarcinomaSemantic proximity Read ↗

EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.